Editorial: CRISPR-aided bioengineering for value-added product development
- PMID: 38152286
- PMCID: PMC10751300
- DOI: 10.3389/fbioe.2023.1340377
Editorial: CRISPR-aided bioengineering for value-added product development
Keywords: CRISPR; CRISPR methylation; CRISPRi; base editor; bioprospecting; biotechnology; computational design; gene editing.
Conflict of interest statement
Author MK was employed by LanzaTech Inc. Author TM was co-founder of Moonshot Bio Inc. The remaining author declares that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. The author(s) declared that they were an editorial board member of Frontiers, at the time of submission. This had no impact on the peer review process and the final decision.
Comment on
- Editorial on the Research Topic CRISPR-aided bioengineering for value-added product development
References
-
- Bloomberg (2022). Statistics on global CRISPR genome editing market size and share to surpass USD 15.84 billion by 2028, exhibit a CAGR of 29.50% . https://www.bloomberg.com/press-releases/2022-06-22/statistics-on-global... (Available at: [Accessed November 14, 2023].
Publication types
LinkOut - more resources
Full Text Sources